UAE Allergy Diagnostics And Therapeutics Market Size & Outlook
UAE allergy diagnostics and therapeutics market, 2018-2030 (US$M)
Related Markets
UAE allergy diagnostics and therapeutics market highlights
- The UAE allergy diagnostics and therapeutics market generated a revenue of USD 149.3 million in 2023 and is expected to reach USD 236.0 million by 2030.
- The UAE market is expected to grow at a CAGR of 6.8% from 2024 to 2030.
- In terms of segment, inhaled was the largest revenue generating allergen type in 2023.
- Other Allergens is the most lucrative allergen type segment registering the fastest growth during the forecast period.
Allergy diagnostics and therapeutics market data book summary
| Market revenue in 2023 | USD 149.3 million |
| Market revenue in 2030 | USD 236.0 million |
| Growth rate | 6.8% (CAGR from 2023 to 2030) |
| Largest segment | Inhaled |
| Fastest growing segment | Other Allergens |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Inhaled, Drug, Other Allergens, Food |
| Key market players worldwide | Rohm Co Ltd, Thermo Fisher Scientific Inc, PerkinElmer, BioMerieux SA, Siemens Healthineers AG ADR, Omega Healthcare Investors Inc, Danaher Corp, Alcon Inc, AbbVie Inc, Sanofi SA, Allergy Therapeutics PLC, Pfizer Inc, Teva Pharmaceutical Industries Ltd, GSK PLC, Sun Pharmaceutical Industries, Roche Holding AG, Merck & Co Inc, Astellas Pharma Inc, Epigenomics AG |
Other key industry trends
- In terms of revenue, UAE accounted for 0.5% of the global allergy diagnostics and therapeutics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia allergy diagnostics and therapeutics market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 236.0 million by 2030.
Inhaled was the largest segment with a revenue share of 54.99% in 2023. Horizon Databook has segmented the UAE allergy diagnostics and therapeutics market based on inhaled, drug, other allergens, food covering the revenue growth of each sub-segment from 2018 to 2030.
The market is anticipated to grow at a lucrative rate over the forecast period due to an increase in the number of allergy cases. It is projected that rising asthma prevalence will fuel market expansion. The market for allergy diagnostics and therapeutics is expected to grow as more public and private groups launch awareness campaigns.
Furthermore, rapid environmental and lifestyle changes along with increasing investments by companies in developing cutting-edge allergy treatments are expected to boost the market growth. For instance, as per the data of IQAir, the average PM 2.5 in the UAE is 7.2 times higher than the WHO annual air quality guidelines.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Allergy Diagnostics And Therapeutics Market Scope
Allergy Diagnostics And Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE allergy diagnostics and therapeutics market size, by allergen type, 2018-2030 (US$M)
UAE Allergy Diagnostics And Therapeutics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
